Loading stock data…
NAII
$2.50-0.01 (-0.60%)
Natural Alternatives International, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Natural Alternatives International, Inc. in the Consumer Defensive sector is trading at $2.50. The stock is currently near its 52-week low of $2.33, remaining 18.7% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$2.50
Potential Downside
0%
Whystock Fair Value$2.50
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Tra...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-22.77%
Volume
Today's trading volume
7,296
Recent News
Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure
NAII's Q3 sales rise 23% y/y, but a wider loss and margin pressure offset gains from stronger contract manufacturing demand.
Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase
NAII posts higher Q2 sales but wider losses, and trims its outlook for fiscal 2026 amid softer customer forecasts and launch delays.
Natural Alternatives: Fiscal Q2 Earnings Snapshot
CARLSBAD, Calif. AP) — Natural Alternatives International Inc. NAII) on Friday reported a loss of $2.6 million in its fiscal second quarter.
Niche Focus & Regulation Shape the Future of Healthcare Firms
CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.
Top Penny Stocks To Watch In November 2025
As the U.S. stock market reacts to blockbuster earnings from companies like Nvidia and Walmart, major indices such as the Dow Jones, Nasdaq, and S&P 500 have shown modest gains. Amid these market movements, penny stocks—often representing smaller or newer companies—continue to be a relevant investment area despite their somewhat outdated label. These stocks can offer growth opportunities at lower price points when supported by strong balance sheets and solid fundamentals, making them an...